HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marcheselli, V. L. Articles by Bazan, N. G. Search for Related Content PubMed PubMed Citation Articles by Marcheselli, V. L. Articles by Bazan, N. G. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 16, 9140-9145, Jun, 1990

Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex

VL Marcheselli, MJ Rossowska, MT Domingo, P Braquet and NG Bazan
Louisiana State University Medical Center School of Medicine, New Orleans 70112.

The binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC or PAF, platelet-activating factor) to synaptic plasma membranes, microsomal membranes, and other rat cerebral cortex subcellular fractions was studied. Using several PAF-binding antagonists, three distinct sites were identified. Two of them were in intracellular membranes (microsomes) and one in synaptic plasma membranes. Microsomal membranes were prepared after obtaining a 43,500 x g pellet from the postmitochondrial supernatant and subsequent centrifugation at 105,000 x g of the resulting supernatant. Most plasma membrane markers were retained in the 43,500 x g pellet (Sun, G.Y., Huang, H.-M., Kelleher, J.A., Stubbs, E.B., Sun, A. Y. (1988) Neurochem. Int. 12, 69-77). Microsomes were purified by density-gradient centrifugation and marker enzymes showed relatively very low contamination by plasma membrane markers. Myelin and mitochondria were devoid of specific PAF binding. A site displaying the highest PAF-binding affinity reported to date in all cells and membranes (KD = 22.5 +/- 1.7 pM and Bmax 8.75 = fmol/mg protein), was found in the microsomal fraction. There was a second binding site in microsomal fractions (KD = 25.0 +/- 0.8 nM and Bmax = 0.96 pmol/mg protein. Ca2+ decreases PAF affinity for the microsomal binding sites. The third binding site displays relatively low specific PAF binding and is present in synaptosomal plasma membranes. Moreover, displacement curves by a wide variety of PAF antagonists indicated different affinities for each of the binding sites described here. These results indicate that PAF-binding sites are heterogeneous in rat cerebral cortex, and they imply that the microsomal membrane sites may be involved, at least in part, in intracellular events such as gene expression.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. D. Ryan, C. S. Harris, C. L. Carswell, J. E. Baenziger, and S. A. L. Bennett Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons J. Lipid Res., October 1, 2008; 49(10): 2250 - 2258. [Abstract] [Full Text] [PDF]

				C. Lemieux, R. Maliba, J. Favier, J.-F. Theoret, Y. Merhi, and M. G. Sirois Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses Blood, February 15, 2005; 105(4): 1523 - 1530. [Abstract] [Full Text] [PDF]

				S. Rosseau, K. Wiechmann, S. Moderer, J. Selhorst, K. Mayer, M. Krull, A. Hocke, H. Slevogt, W. Seeger, N. Suttorp, et al. Moraxella catarrhalis-Infected Alveolar Epithelium Induced Monocyte Recruitment and Oxidative Burst Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 157 - 166. [Abstract] [Full Text] [PDF]

				F. Bonin, S. D. Ryan, L. Migahed, F. Mo, J. Lallier, D. J. Franks, H. Arai, and S. A. L. Bennett Anti-apoptotic Actions of the Platelet-activating Factor Acetylhydrolase I {alpha}2 Catalytic Subunit J. Biol. Chem., December 10, 2004; 279(50): 52425 - 52436. [Abstract] [Full Text] [PDF]

				S. Rollin, C. Lemieux, R. Maliba, J. Favier, L. R. Villeneuve, B. G. Allen, S. Soker, N. G. Bazan, Y. Merhi, and M. G. Sirois VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis Blood, May 15, 2004; 103(10): 3789 - 3797. [Abstract] [Full Text] [PDF]

				N. G. Bazan Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor J. Lipid Res., December 1, 2003; 44(12): 2221 - 2233. [Abstract] [Full Text] [PDF]

				A. M. Marrache, F. Gobeil Jr., S. G. Bernier, J. Stankova, M. Rola-Pleszczynski, S. Choufani, G. Bkaily, A. Bourdeau, M. G. Sirois, A. Vazquez-Tello, et al. Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor J. Immunol., December 1, 2002; 169(11): 6474 - 6481. [Abstract] [Full Text] [PDF]

				M. H. Beauchamp, A. M. Marrache, X. Hou, F. Gobeil Jr, S. G. Bernier, P. Lachapelle, D. Abran, C. Quiniou, S. Brault, K. G. Peri, et al. Platelet-Activating Factor in Vasoobliteration of Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3327 - 3337. [Abstract] [Full Text] [PDF]

				C. Chen, J. C. Magee, V. Marcheselli, M. Hardy, and N. G. Bazan Attenuated LTP in Hippocampal Dentate Gyrus Neurons of Mice Deficient in the PAF Receptor J Neurophysiol, January 1, 2001; 85(1): 384 - 390. [Abstract] [Full Text] [PDF]

				G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF]

				P. K. Mukherjee, M. A. DeCoster, F. Z. Campbell, R. J. Davis, and N. G. Bazan Glutamate Receptor Signaling Interplay Modulates Stress-sensitive Mitogen-activated Protein Kinases and Neuronal Cell Death J. Biol. Chem., March 5, 1999; 274(10): 6493 - 6498. [Abstract] [Full Text] [PDF]

				K. R. Bartemes, S. McKinney, G. J. Gleich, and H. Kita Endogenous Platelet-Activating Factor Is Critically Involved in Effector Functions of Eosinophils Stimulated with IL-5 or IgG J. Immunol., March 1, 1999; 162(5): 2982 - 2989. [Abstract] [Full Text] [PDF]

				S. Grassi, E. Francescangeli, G. Goracci, and V. E. Pettorossi Role of Platelet-Activating Factor in Long-Term Potentiation of the Rat Medial Vestibular Nuclei J Neurophysiol, June 1, 1998; 79(6): 3266 - 3271. [Abstract] [Full Text] [PDF]

				P. Bac, P. Maurois, C. Dupont, N. Pages, J. P. Stables, P. Gressens, P. Evrard, and J. Vamecq Magnesium Deficiency-Dependent Audiogenic Seizures (MDDASs) in Adult Mice: A Nutritional Model for Discriminatory Screening of Anticonvulsant Drugs and Original Assessment of Neuroprotection Properties J. Neurosci., June 1, 1998; 18(11): 4363 - 4373. [Abstract] [Full Text] [PDF]

				U. Staubli, D. Chun, and G. Lynch Time-Dependent Reversal of Long-Term Potentiation by an Integrin Antagonist J. Neurosci., May 1, 1998; 18(9): 3460 - 3469. [Abstract] [Full Text] [PDF]

				T. Dohi, K. Itadani, H. Yamaki, Y. Akagawa, K. Morita, and S. Kitayama Stimulation of Platelet-activating Factor Synthesis by Neurotransmitters in Salivary Glands Journal of Dental Research, January 1, 1997; 76(1): 568 - 574. [Abstract] [PDF]

				V. L. Marcheselli and N. G. Bazan Sustained Induction of Prostaglandin Endoperoxide Synthase-2 by Seizures in Hippocampus. INHIBITION BY A PLATELET-ACTIVATING FACTOR ANTAGONIST J. Biol. Chem., October 4, 1996; 271(40): 24794 - 24799. [Abstract] [Full Text] [PDF]

				R Schaloske, C Sordano, S Bozzaro, and D Malchow Stimulation of calcium influx by platelet activating factor in Dictyostelium J. Cell Sci., January 4, 1995; 108(4): 1597 - 1603. [Abstract] [PDF]